Medicine and Dentistry
Xenograft
100%
Neoplasm
75%
Rhabdomyosarcoma
63%
Pediatrics
57%
Patient
48%
Cells
46%
In Vitro
43%
Solid Malignant Neoplasm
40%
Combination Therapy
38%
Therapeutic Procedure
35%
Tumor Xenograft
28%
Cell Line
27%
Acute Lymphoblastic Leukemia
26%
Topotecan
24%
Rapamycin
24%
Ewing Sarcoma
23%
Childhood Cancer
22%
Vincristine
20%
Ganglioneuroblastoma
19%
Malignant Neoplasm
18%
Childhood
18%
Child
17%
Growth
16%
Development
16%
Osteosarcoma
15%
Irinotecan
15%
Diseases
13%
Sarcoma
13%
Chemotherapeutic Agent
13%
Drug
13%
Tissues
13%
Mechanistic Target of Rapamycin
12%
Tumor Model
12%
Radiation Therapy
11%
Antineoplastic Activity
11%
Pediatric Cancer
11%
Adult
11%
Programmed Cell Death
11%
Wilms' Tumor
11%
Event Free Survival
11%
Differentiation
11%
Cytotoxicity
11%
Cyclophosphamide
10%
IC50
10%
Evaluation Study
9%
Somatomedin C Receptor
9%
Anticarcinogen
9%
Phosphorylation
9%
Gene
9%
Survival
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
94%
Solid Malignant Neoplasm
46%
Mouse
44%
Irinotecan
43%
Rhabdomyosarcoma
39%
Topotecan
36%
Vincristine
34%
Malignant Neoplasm
26%
Drug
25%
Toxicity
19%
Tritium
18%
Cytotoxicity
17%
Osteosarcoma
17%
Childhood Cancer
16%
Mammalian Target of Rapamycin
16%
Acute Lymphoblastic Leukemia
16%
Clinical Trial
15%
Ewing Sarcoma
15%
Anticarcinogen
15%
Colon Adenocarcinoma
15%
Tumor Model
14%
Pharmacokinetics
14%
Neuroblastoma
14%
Maximum Tolerated Dose
13%
DNA
12%
Temozolomide
12%
Antitumor Activity
12%
Sarcoma
11%
IC50
11%
Diseases
10%
Lactone
10%
Camptothecin
10%
Cyclophosphamide
10%
Protein
9%
Event Free Survival
9%
Fluorouracil
9%
Thymidylate Synthase
9%
Glioblastoma
8%
Tumor Growth
8%
Chemotherapy
8%
P-Glycoprotein
8%
Survival
8%
Verapamil
7%
Protein P53
7%
DNA Topoisomerase
7%
Tumor Regression
7%
Nephroblastoma
7%
Antibody
7%
Cytotoxic Agent
6%
Metastasis
6%
Biochemistry, Genetics and Molecular Biology
Pediatrics
45%
Solid
34%
Mouse
24%
Growth
21%
Childhood
18%
Mammalian Target of Rapamycin
18%
Ewing's Sarcoma
18%
Phosphorylation
14%
Nested Gene
14%
Colon
13%
Dose
13%
Protein
12%
Antineoplastic Activity
12%
Kinase
12%
Development
11%
IC50
10%
Thymidylate Synthase
10%
Time
9%
Cancer Cell
9%
Electric Potential
8%
Lysozyme
8%
Regulatory Mechanism
8%
Cell Proliferation
7%
P53
7%
Mutation
7%
Cytotoxicity
7%
Event Free Survival
6%
Apoptosis
6%
Fluorouracil
6%
DNA
6%
Sample
6%
Mammalian Target of Rapamycin Complex 1
6%
Survival
6%
Clone
6%
Signal Transduction
5%
Mutant
5%
FLI1
5%
STAT3
5%
Cyclophosphamide
5%
Phenotype
5%
Wilms' Tumor
5%
Bone
5%
Contrast
5%